Bringing scientists, journalists and policymakers together : communicate better sound science to all!
Combining so-called “backward tracing” with traditional forward tracing to help identify source events of COVID-19 outbreaks has been cited as a potential way of better tracking the disease, as seen in some Asian countries. Now that vaccines are emerging on the scene, how can this concept be used for more effective cluster-busting?
The COVID-19 pandemic has accelerated the digitalisation of our daily lives and, by now, we are all a bit more dependent on technology than we had been before. But how can we trust all the scientific information that we receive through the media? How can we have a common understanding of what is reliable when we are being exposed to massive online information flows? Do we trust the same truths? What kind of people are more susceptible to trusting conspiracy theories? Using a novel approach based on social science, the new EU-funded project TRESCA tackles these, and other, research questions.
During the Coronavirus crises, the European Science-Media Hub is collecting and publishing a regular update of the most relevant releases provided by EU institutions and other European and global actors. 🆕 Last Update : 11 Jan 2021
Dr. Philipp Schmid is a scientific researcher at the Department of Psychology at the University of Erfurt (Germany). Philipp’s research aims at analysing the psychological reasons of science denialism. He is the lead author of the WHO guideline on how to respond to vocal vaccine denier in public and a co-author of the Debunking Handbook ...
The coronavirus pandemic has accelerated digitalization and the adoption of new technologies that are having a profound effect on the way we work. It has highlighted the urgent need to protect workers’ rights and to adopt measures that ensure inclusive growth and close the digital divide.
As multiple COVID-19 vaccines are emerging, what can be done to tackle vaccination hesitancy and ensure rapid and equitable deployment?
COVID-19 misinformation, climate crisis & internet of things. Check out the ESMH selection of 20 science and tech news published in the last weeks on the web.
Scientists around the world are working hard to come up with a COVID-19 vaccine to suppress the pandemic. How can the EU guarantee that rapidly approved vaccines are safe and effective? We asked senior representatives from the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) for their thoughts.
Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.
A few weeks after the SARS-CoV-2 was identified by Chinese researchers as the cause of ‘COVID-19’, an antiviral called remdesivir, originally used during the 2014 Ebola outbreak, came into play as the first available option to treat patients with coronavirus disease 2019 (COVID-19). Even if the approval process for remdesivir caused some controversy, experts consider the combined use of antivirals and other drugs a promising solution for treatment of Covid-19.
Renewable energy, Robots, and Covid-19 vaccines : Check out the ESMH selection of 20 science and tech news published in the last weeks on the web.
Digital well-being tools hold the promise of empowering users to regain control of time spent online. How successful are these tools during the Covid-19 global pandemic?
